135 results on '"Wermes C"'
Search Results
2. Spectrum of Molecular Defects and Mutation Detection Rate in Patients with Mild and Moderate Hemophilia A
3. Update of the Inhibitor-Immunology-Study
4. Spectrum of Molecular Defects and Mutation Detection Date in Patients with Severe Hemophilia A
5. Immune Tolerance in an Inhibitor Patient with Severe Hemophilia A — Comparison of two Different Treatment Schedules Including Rituximab
6. Presentation of the Inhibitor-Immunology-Study
7. Bolus Injection of Recombinant Factor VIIa (NovoSeven) can be More Effective than Continuous Infusion in Inhibitor Patients with Severe Hemophilia A
8. Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children
9. Expression of Protease-activated Receptors in Neuroblastoma Cells
10. Isolated molecular Defects of von Willebrand Factor Binding to Collagen do not correlate with Bleeding Symptoms
11. Symptomatic Onset of severe Hemophilia A in Childhood is dependent on the Presence of Prothrombotic Risk Factors
12. Role of a 23 bp Insertion in Exon 3 of the Endothelial Cell Protein C Receptor Gene in Venous Thrombophilia
13. Severe Neonatal Thrombosis in a Patient with Factor V Q:506 Mutation and the G20210A Prothrombin Mutation
14. Thrombophilie bei akuter lymphoblastischer Leukämie (ALL) und Mukoviszidose
15. Gendefekte als Ursache für Thrombosen in der pädiatrischen Onkologie
16. Stellenwert und Prävalenz der Prothrombin-G20210A-Mutation bei Patienten mit hereditärer Thrombophilie
17. Two Examples of the Influence of Psychological Stress on the von Willebrand Factor Activity
18. Mutation Detection Rate in Female Patients with Reduced Factor VIII Activity and Negative Family History for Hemophilia A
19. Immunthrombocytopenia and Lupus Antibodies in a Patient with Hemophilia A
20. Keine Dosisreduktion des vWF-Konzentrates trotz kontinuierlicher Infusionstherapie bei erworbenem von-Willebrand-Syndrom
21. Development of annual joint bleeds and factor consumption during the last 6 years in 14 haemophilia centers - real life data from electronic documentation smart medication
22. Joint bleeds and pain related treatment – comparison of data between 2017 and 2019 according to electronic diary smart-medication
23. Annual bleeding rate and factor consumption – comparison between extended and short half-life factor VIII in real life according to electronic documentation smart medication
24. Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A
25. Haemate® P for the treatment of vWD and haemophilia A: new results of a pharmacovigilance project: PB 3.37–4
26. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin
27. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters
28. Isolated Molecular Defects of von Willebrand Factor Binding to Collagen do not correlate with Bleeding Symptoms
29. Expression of Protease-activated Receptors in Neuroblastoma Cells
30. Quality of life and bleeding of carriers of Hemophilia A and B - results of the carrier-QoL-Study: 25 PO 815
31. Haemophilia summer camps in Germany, 1996-2005: 19 PO 637
32. Health status and health-related quality of life of children with haemophilia from six West European countries
33. Severe protein C deficiency and aseptic osteonecrosis of the hip joint: a case report
34. The use of the PFA-100 in children with lupus antcoagulant
35. Thermography as a Component of Telemedicine for Diagnosis, Therapy and Follow-up of Joint Bleeding, Soft-tissue Bleeding and Micro-bleeding
36. Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medicationTM
37. Systematic Comparison of MRI and ultrasound scores to Assess Arthropathy in Children and Adolescents with Hemophilia
38. Comparison of Electronic Documentation with Smart Medicationtm between 2014 and 2017
39. Treatment Pattern and Pain Related to Joint Bleeds and Non-joint Bleeds - real Life Data According to Electronic Diary Smart-medicationTM.
40. Comparison of Electronic Documentation with Smart Medicationtm between 2014 and 2017.
41. MYH9-related disease - Report on 5 German families and description of a novel mutation. Ann Hematol 89:1057-1059, 2010
42. Presentation of the Inhibitor-Immunology-Study
43. Spectrum of Molecular Defects and Mutation Detection Rate in Patients with Mild and Moderate Hemophilia A
44. Update of the Inhibitor-Immunology-Study
45. Spectrum of Molecular Defects and Mutation Detection Date in Patients with Severe Hemophilia A
46. Therapie hereditärer Thrombozytopathien
47. Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin
48. Prioritisation in Haemophilia A: A Qualitative Study of Stakeholder Attitudes and Preferences
49. Successful long-time treatment with mycophenolate-mofetil in a child with acquired factor VIII inhibitor
50. Inhibitor-Immunology-Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.